Successful management of aortoesophageal fistula caused by esophageal cancer using thoracic endovascular aortic repair
Autor: | Tsutomu Namikawa, Keiichiro Yokota, Nobuyuki Hirose, Hiroyuki Kitagawa, Kazuki Kihara, Kazuhiro Hanazaki, Jun Iwabu |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
medicine.medical_specialty Esophageal Neoplasms medicine.medical_treatment Aorta Thoracic 03 medical and health sciences 0302 clinical medicine Surgical oncology medicine.artery Humans Medicine Thoracic aorta Aged Vascular Fistula Chemotherapy business.industry Endovascular Procedures Gastroenterology Cancer General Medicine Esophageal cancer medicine.disease Colorectal surgery Surgery Radiation therapy 030220 oncology & carcinogenesis 030211 gastroenterology & hepatology Esophageal Squamous Cell Carcinoma business Abdominal surgery |
Zdroj: | Clinical Journal of Gastroenterology. 13:678-682 |
ISSN: | 1865-7265 1865-7257 |
DOI: | 10.1007/s12328-020-01132-5 |
Popis: | Aortoesophageal fistula (AEF) is a highly life-threatening condition, even when treated promptly. However, little is known about the treatment for AEF in patients with advanced esophageal cancer. We report the case of a 69-year-old man diagnosed with esophageal squamous cell carcinoma (ESCC) that was admitted to our hospital for ESCC treatment. On diagnosis of unresectable ESCC invading the thoracic aorta, chemotherapy was administered. The response to treatment after two courses was evaluated as stable disease. We performed radiation therapy followed by bypass operation for esophageal stenosis. After radiation therapy, AEF was detected. His condition improved after hemostasis using thoracic endovascular aortic repair (TEVAR). He was discharged from our care after treatment with antibiotics; he died due to cancer progression 7 months after TEVAR. AEF with ESCC is a lethal condition that may occur during cancer treatment; however, TEVAR might help improve the patient's condition. |
Databáze: | OpenAIRE |
Externí odkaz: |